FRANKFURT (Reuters) – German pharmaceuticals and agriculture group Bayer on Monday confirmed its 2023 sales and earnings guidance and reiterated that business would not really pick up before the second half of the year.
“We are expecting business to be relatively sluggish in the first half-year compared with the very strong previous year,” Chief Executive Werner Baumann said in a speech to be held at Bayer’s annual shareholder meeting on Friday, which was posted in writing on the company’s website on Monday.
($1 = 0.9068 euros)
(Reporting by Ludwig Burger and Patricia Weiss; Editing by Susan Fenton)
